SEI Trust Company’s Novo Nordisk NVO Stock Holding History

SEI Trust Company’s Portfolio NVO Stock Details NVO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2014 Q3	$3.66M	Buy	153,730 +57,280	+59%	+$1.32M	0.04%	489
2014 Q2	$2.23M	Hold	96,450	–	–	0.02%	637
2014 Q1	$2.2M	Buy	96,450 +12,200	+14%	+$260K	0.02%	640
2013 Q4	$1.56M	Buy	84,250 +1,000	+1%	+$17.4K	0.01%	780
2013 Q3	$1.41M	Sell	83,250 -41,150	-33%	-$692K	0.02%	755
2013 Q2	$1.93M	Buy	+124,400	New	+$2.07M	0.02%	580

Other funds holding NVO

Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return

JSP

Jackson Square Partners Larkspur, California $247M AUM 20.29% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Fayez Sarofim & Co Houston, Texas $39.1B AUM 15.14% 1-Year Est. Return

Loomis, Sayles & Company Boston, Massachusetts $74.3B AUM 24.01% 1-Year Est. Return

Arrowstreet Capital Boston, Massachusetts $185B AUM 39.58% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

SEI Trust Company's NVO Position: Q3 2014 in Review

SEI Trust Company increased its Novo Nordisk (NVO) stake by 59% in Q3 2014, buying an estimated $1.32M and bringing the position to 153,730 shares worth $3.66M. The position accounts for 0.04% of the portfolio, ranked #489.

SEI Trust Company first reported a position in NVO in Q2 2013 and has held it in 6 quarters since. 470 funds tracked by Wall St. Rank hold NVO as of Q3 2014.

SEI Trust Company held 153,730 shares of Novo Nordisk worth $3.66M as of Q3 2014.
SEI Trust Company bought 57,280 Novo Nordisk shares in Q3 2014, an estimated $1.32M.
Novo Nordisk made up 0.04% of SEI Trust Company's portfolio in Q3 2014, its #489 holding.
SEI Trust Company first reported a position in Novo Nordisk in Q2 2013 and has held it in 6 quarters since.
470 funds tracked by Wall St. Rank held Novo Nordisk as of Q3 2014.

Based on SEI Trust Company's 13F filing for Q3 2014, filed 28 Oct 2014.